Cargando…

Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain

Background and objectives: Glycerol phenylbutyrate (GPB) has demonstrated safety and efficacy in patients with urea cycle disorders (UCDs) by means of its clinical trial program, but there are limited data in clinical practice. In order to analyze the efficacy and safety of GPB in clinical practice,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martín-Hernández, Elena, Quijada-Fraile, Pilar, Correcher, Patricia, Meavilla, Silvia, Sánchez-Pintos, Paula, de las Heras Montero, Javier, Blasco-Alonso, Javier, Dougherty, Lucy, Marquez, Ana, Peña-Quintana, Luis, Cañedo, Elvira, García-Jimenez, María Concepción, Moreno Lozano, Pedro Juan, Murray Hurtado, Mercedes, Camprodon Gómez, María, Barrio-Carreras, Delia, de los Santos, Mariela, del Toro, Mireia, Couce, María L., Vitoria Miñana, Isidro, Morales Conejo, Montserrat, Bellusci, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457033/ https://www.ncbi.nlm.nih.gov/pubmed/36078975 http://dx.doi.org/10.3390/jcm11175045

Ejemplares similares

Breastfeeding and Inborn Errors of Amino Acid and Protein Metabolism: A Spreadsheet to Calculate Optimal Intake of Human Milk and Disease-Specific Formulas
por: Vitoria-Miñana, Isidro, et al.
Publicado: (2023)

Direct replacement of oral sodium benzoate with glycerol phenylbutyrate in children with urea cycle disorders
por: Yeo, Mildrid, et al.
Publicado: (2022)

Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease
por: Sánchez-Pintos, Paula, et al.
Publicado: (2022)

Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy
por: Rockey, Don C, et al.
Publicado: (2014)

Clinical experience with glycerol phenylbutyrate in 20 patients with urea cycle disorders at a UK paediatric centre
por: Yeo, Mildrid, et al.
Publicado: (2023)

Transferrin Isoforms, Old but New Biomarkers in Hereditary Fructose Intolerance
por: Cano, Ainara, et al.
Publicado: (2021)

Vitamin C and folate status in hereditary fructose intolerance
por: Cano, Ainara, et al.
Publicado: (2022)

Correction: Vitamin C and folate status in hereditary fructose intolerance
por: Cano, Ainara, et al.
Publicado: (2023)

Protein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate()
por: Hook, Debra, et al.
Publicado: (2016)

Severe loss of appetite and refusal to eat as severe side effect of glycerol phenylbutyrate
por: Grünert, Sarah Catharina, et al.
Publicado: (2022)

Secondary Ammonia Scavenge With Glycerol Phenylbutyrate Improves Hyperammonemia Following Portosystemic Shunting
por: Kortbeek, Simone, et al.
Publicado: (2022)

Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate
por: Mokhtarani, M., et al.
Publicado: (2015)

Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders
por: Longo, Nicola, et al.
Publicado: (2020)

Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases
por: Martín-Hernández, Elena, et al.
Publicado: (2014)

Carbohydrate status in patients with phenylketonuria
por: Couce, María L., et al.
Publicado: (2018)

Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience
por: Quijada-Fraile, Pilar, et al.
Publicado: (2021)

Elosulfase alfa for mucopolysaccharidosis type IVA: Real-world experience in 7 patients from the Spanish Morquio-A early access program
por: Pintos-Morell, Guillem, et al.
Publicado: (2018)

Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: patient perspectives
por: Peña-Quintana, Luis, et al.
Publicado: (2017)

Influence of food on pharmacokinetics and pharmacodynamics of 4-phenylbutyrate in patients with urea cycle disorders
por: Nakajima, Yoko, et al.
Publicado: (2021)

Clinical and Experimental Applications of Sodium Phenylbutyrate
por: Iannitti, Tommaso, et al.
Publicado: (2012)

Identification of enzymes involved in oxidation of phenylbutyrate
por: Palir, Neža, et al.
Publicado: (2017)

Phenylbutyrate increases activity of pyruvate dehydrogenase complex
por: Ferriero, Rosa, et al.
Publicado: (2013)

4-PHENYLBUTYRATE: MOLECULAR MECHANISMS AND AGING INTERVENTION POTENTIAL
por: Bene, Michael R, et al.
Publicado: (2019)

Phenylbutyrate facilitates homeostasis of non-resolving inflammatory macrophages
por: Rahtes, Allison, et al.
Publicado: (2019)

Lipid profile status and other related factors in patients with Hyperphenylalaninaemia
por: Couce, María L., et al.
Publicado: (2016)

Clinical Utility of LCT Genotyping in Children with Suspected Functional Gastrointestinal Disorder
por: Couce, María L., et al.
Publicado: (2020)

Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator
por: Gondcaille, Catherine, et al.
Publicado: (2005)

Effect of sodium 4-phenylbutyrate on Clenbuterol-mediated muscle growth
por: Brown, David M., et al.
Publicado: (2018)

4-phenylbutyrate Mitigates Fluoride-Induced Cytotoxicity in ALC Cells
por: Suzuki, Maiko, et al.
Publicado: (2017)

Comparison Between Dichloroacetate and Phenylbutyrate Treatment for Pyruvate Dehydrogenase Deficiency
por: Karissa, Patricia, et al.
Publicado: (2022)

Identification of Clinical Variants beyond the Exome in Inborn Errors of Metabolism
por: Soriano-Sexto, Alejandro, et al.
Publicado: (2022)

Lymphocyte Medium-Chain Acyl-CoA Dehydrogenase Activity and Its Potential as a Diagnostic Confirmation Tool in Newborn Screening Cases
por: Alcaide, Patricia, et al.
Publicado: (2022)

Recommendations for the Diagnosis and Therapeutic Management of Hyperammonaemia in Paediatric and Adult Patients
por: Bélanger-Quintana, Amaya, et al.
Publicado: (2022)

Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
por: Delgado, Teresa C., et al.
Publicado: (2022)

Evaluation of Body Composition, Physical Activity, and Food Intake in Patients with Inborn Errors of Intermediary Metabolism
por: de Castro, María-José, et al.
Publicado: (2021)

Modulation of Toxin Stability by 4-Phenylbutyric Acid and Negatively Charged Phospholipids
por: Ray, Supriyo, et al.
Publicado: (2011)

ER retention is imposed by COPII protein sorting and attenuated by 4-phenylbutyrate
por: Ma, Wenfu, et al.
Publicado: (2017)

Neuroprotective Effect of 4-Phenylbutyric Acid against Photo-Stress in the Retina
por: Guzmán Mendoza, Naymel Alejandra, et al.
Publicado: (2021)

4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations
por: Tominaga, Kana, et al.
Publicado: (2021)

Similarities between acylcarnitine profiles in large for gestational age newborns and obesity
por: Sánchez-Pintos, Paula, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ggf4tvkm9inggfh3raufeeecgm